Smith, Salley & Associates Pfizer Inc Transaction History

Smith, Salley & Associates

$1.48 Billion
Q3 2024

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Jan 24, 2024	SELL	$26.13 - $33.94 $268,538 - $348,801	-10,277 Reduced 46.28%	11,929 $343,000
Q3 2023 Oct 27, 2023	SELL	$32.09 - $37.51 $61,612 - $72,019	-1,920 Reduced 7.96%	22,206 $736,000
Q2 2023 Aug 04, 2023	SELL	$36.12 - $41.79 $50,712 - $58,673	-1,404 Reduced 5.5%	24,126 $884,000
Q1 2023 May 03, 2023	BUY	$39.39 - $51.28 $2,324 - $3,025	59 Added 0.23%	25,530 $1.04 Million
Q4 2022 Feb 03, 2023	BUY	$41.75 - $54.5 $12,525 - $16,350	300 Added 1.19%	25,471 $1.31 Million
Q3 2022 Nov 01, 2022	BUY	$43.76 - $53.42 $15,928 - $19,444	364 Added 1.47%	25,171 $1.1 Million
Q2 2022 Aug 01, 2022	SELL	$46.53 - $55.17 $47,507 - $56,328	-1,021 Reduced 3.95%	24,807 $1.3 Million
Q1 2022 May 10, 2022	SELL	$45.75 - $56.69 $51,514 - $63,832	-1,126 Reduced 4.18%	25,828 $1.34 Million
Q4 2021 Feb 10, 2022	SELL	$41.32 - $61.25 $11,652 - $17,272	-282 Reduced 1.04%	26,954 $1.59 Million
Q3 2021 Nov 05, 2021	SELL	$39.25 - $50.42 $38,857 - $49,915	-990 Reduced 3.51%	27,236 $1.17 Million
Q2 2021 Aug 09, 2021	BUY	$35.91 - $40.68 $23,844 - $27,011	664 Added 2.41%	28,226 $1.11 Million
Q1 2021 Apr 30, 2021	SELL	$33.49 - $37.77 $2.02 Million - $2.28 Million	-60,373 Reduced 68.66%	27,562 $999,000
Q4 2020 Jan 28, 2021	SELL	$33.47 - $42.56 $770,445 - $979,688	-23,019 Reduced 20.75%	87,935 $3.24 Million
Q3 2020 Nov 05, 2020	BUY	$31.75 - $37.25 $5,556 - $6,518	175 Added 0.16%	110,954 $4.07 Million
Q2 2020 Aug 04, 2020	BUY	$30.12 - $36.54 $150,178 - $182,188	4,986 Added 4.71%	110,779 $3.62 Million
Q1 2020 Apr 24, 2020	SELL	$27.03 - $38.62 $68,061 - $97,245	-2,518 Reduced 2.32%	105,793 $3.45 Million
Q4 2019 Jan 27, 2020	BUY	$32.92 - $37.36 $11,785 - $13,374	358 Added 0.33%	108,311 $4.24 Million
Q3 2019 Oct 30, 2019	BUY	$32.49 - $42.13 $157,479 - $204,204	4,847 Added 4.7%	107,953 $3.88 Million
Q2 2019 Jul 12, 2019	SELL	$36.98 - $41.52 $195,513 - $219,516	-5,287 Reduced 4.88%	103,106 $4.47 Million
Q1 2019 May 03, 2019	BUY	$37.5 - $41.2 $39,787 - $43,713	1,061 Added 0.99%	108,393 $4.6 Million
Q4 2018 Feb 05, 2019	SELL	$38.47 - $43.86 $174,846 - $199,343	-4,545 Reduced 4.06%	107,332 $4.69 Million
Q3 2018 Nov 06, 2018	SELL	$34.47 - $41.81 $134,639 - $163,309	-3,906 Reduced 3.37%	111,877 $4.93 Million
Q2 2018 Aug 10, 2018	SELL	$32.98 - $35.16 $21,074 - $22,467	-639 Reduced 0.55%	115,783 $4.2 Million
Q1 2018 May 09, 2018	BUY	$31.91 - $37.02 $37,302 - $43,276	1,169 Added 1.01%	116,422 $4.13 Million
Q4 2017 Feb 12, 2018	BUY	$33.26 - $35.29 $78,693 - $83,496	2,366 Added 2.1%	115,253 $4.18 Million
Q3 2017 Nov 02, 2017	BUY	$31.0 - $34.15 $3.5 Million - $3.86 Million	112,887	112,887 $4.03 Million

Others Institutions Holding PFE

# of Institutions

3,260

Shares Held

3.73B

Call Options Held

73.5M

Put Options Held

108M

Vanguard Group Inc Valley Forge, PA

511M
Shares

$13.4 Billion
0.28% of portfolio
Black Rock Inc. New York, NY

424M
Shares

$11.1 Billion
0.27% of portfolio
State Street Corp Boston, MA

287M
Shares

$7.53 Billion
0.36% of portfolio
Wellington Management Group LLP Boston, MA

166M
Shares

$4.36 Billion
0.85% of portfolio
Charles Schwab Investment Management Inc San Francisco, CA

130M
Shares

$3.41 Billion
0.73% of portfolio

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $147B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Smith, Salley & Associates, based on Form 13F filings with the SEC.

News

Stay updated on Smith, Salley & Associates with notifications on news.

Account